A composition containing the plasmalogen, which for enhancing memorizing capability
CN111278435A
Pharmaceutical composition, method for stabilizing pharmaceutical composition, and method for evaluating storage stability of pharmaceutical composition
WO2019171619A1
Method for producing plasmalogen-containing composition
WO2018221480A1
Portal vein thrombosis therapeutic agent
JP2015074610A
Immunoglobulin liquid composition
JP2015071559A
Composition for inhibiting il-17 production
EP2783709A1
Submucosal cushioning agent
EP2564858A1
Composition for the treatment of aesthenopia
JP2012219082A
Fusion protein
WO2011125930A1
Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neuropathy
JP2012121870A
Prophylactic or therapeutic agent of acute hepatitis or fulminant hepatitis, and prophylactic or therapeutic agent of asthma
TW201116292A
Agent for prevention or treatment of inflammatory bowel diseases
JP2010070558A
Chondroitin sulfate-iron colloid
JP2010120937A
Inflammatory disease preventing and treating agent containing amino acid fragment of human apolipoprotein a-ii or its modification
JP2011032188A
Fused protein
JP2010077104A
Aqueous injection solution of 3-methyl-1-phenyl-2-pyrazoline-5-one
WO2008133225A1
Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis
JP2010208946A
Preventive and therapeutic agent for rheumatoid arthritis
JP2008133201A
Prophylactic or therapeutic agent for hyperlipemia
